ards (case study)
TRANSCRIPT
Patrick Laird, DNP(C), MSN, RN, ACNP-BC, CCRN;Susan D. Ruppert, PhD, RN, ANP-BC, NP-C, FCCM, FAANP,
2011. Published on Wolters Kluwer Health
Case Study
Pathophysiology of the disease
ECMO Summary
First patient encounter Day 2-4
V/S P/E Lab result CXR Plan
Outline:
55 y/o male recently diagnosed with influenza A. Presented to the emergency department (ED)
accompanied by his wife with worsening shortness of breath, fever, productive cough ( green ) sputum,
and new onset altered mental status.
Primary assessment revealed oxygen saturation of 61% on room air. Respirations were labored with abdominal accessory muscle use.
BIPAP was used but his respiratory status continued to deteriorate ------- ( intubation ) .
Difficult intubation.
After intubation the patient became hypotensive. A Levophed drip was initiated.
Once hemodynamically stable the patient was admitted to the intensive care unit (ICU) for continued management.
Continue
CHIEF COMPLAINT :“Shortness of breath and confusion” PAST MEDICAL AND SURGICAL HISTORY :
• Hypertension — Diagnosed in 2009.• Hyperlipidemia — Diagnosed in 2009.• No history of surgical procedures.• Denied any history of smoking and drinks approximately 2 alcoholic beverages per week.
SOCIAL AND FAMILY HISTORY :Married for 28 years , Employed with Anadarko
petroleum division. His parents both diagnosed with hypertension treated with medication.
CURRENT HOSPITAL MEDICATIONS : Levophed infusion at 0.4 μg/kg/min
intravenous (IV). Propofol infusion at 55 μg/kg/min IV. Protonix 40 mg IV daily. Lovenox 40 mg subcutaneous daily. Azithromycin 500 mg IV daily.
REVIEW OF SYSTEMS :Patient orally intubated at the time of interview and
examination. Chest :Complains of increased dyspnea and cough with
increased green sputum production 2 days prior to admission.
Heart: Complains of weakness for 10 days prior to
arrival. Urinary system:decrease in normal urinary output because of
decreased oral intake.
Neurological :His wife reports change in his mental status over last 2 days. States patient is “not making any sense and is saying inappropriate things.
Day 2
Vt: 700mL = 8mL/Kg PEEP 10 cm H2ORR 18 bpm
FiO2 100%
Vent management:IBW = 90 Kg
A/C VCTube size 8 Fr, at point of 22 near lip line.
VS:
Temp.: 37.2oC. HR: 93b/min. RR: 16 b/min. BP: 89\50 mmHg. O2 Sat.: 86%
Day 2
Overall status: General: well nourished. Skin: No skin rashes/lesions
observed. HEENT. Chest: Symmetrical expansion. Heart: (S1, S2) are noted. Regular
rhythm. No murmurs, gallops, or rubs are appreciated.
Abdomen: Soft, nontender and nondistended.
Day 2
Cont. Extremities: Warm. No edema, clubbing, or
cyanosis was appreciated. Capillary refill: +2 seconds. Nail beds are
pale. Neurological: Sedated on mechanical
ventilation.
Spontaneous movement of all 4 extremities is noted. Does not follow verbal commands.
Day 2
CXR:
Endotracheal tube tip located 2 cm above the carina.
Interval worsening perihilar air space opacity suggestive of worsening pulmonary edema or ARDS.
No pneumothorax or pleural effusion.
Day 2
ABG:
parameters ValuespH: 7.42
PCO2: 41 mmHg.PO2: 34 mmHg.
HCO3: 26 mmol/L
Normal acid base balance with sever hypoxemia.
Day 2
CBC
WBC 10.2 kg/mm3 4.0-10 kg/mm3Hb 15.1 gm/dL 13.0-16.8 gm/dL
Platelets
325 kg/mm3 150-430 kg/mm3
Na 143 mEq/L 135-148 mEq/LK 3.9 mEq/L 3.5-5.5 mEq/LCl 97 mEq/L 98-106 mEq/L
BUN 42 mg/dL 10-26 mg/dLCret. 2.2Mg/dL 0.5-1.2 mg/dLBNP 18 0-100 pg/mL
Day 2
DIAGNOSTIC IMPRESSIONS
Differential Diagnoses:ALI, ARDS,
pneumonia, cardiogenic
pulmonary edema, PE.
Working diagnosis Acute
respiratory distress syndrome (ARDS).
Additional Diagnoses: CAP,
severe sepsis, recent influenza A (H1N1), and acute
renal failure.
Day 2
ARDS
Berlin definition:ARDS is an acute, diffuse, inflammatory lung injury , defined by:
Severity is defined by degree of oxygenation impairment.
RISK FACTORS: Direct “pulmonary etiologies” Indirect “extrapulmonary etiologies”?
Pneumonia. Aspiration. Inhalational injury. Pulmonary contusion. Fat emboli.
Sepsis. massive blood transfusion. Burns. Acute pancreatitis. Severe trauma.
Pneumonia35%
Sever Sepsis26%
Aspiration15%
Trauma11%
Other13%
Causes of ARDS
June 20, 2012,
Pathophysiology:
↓ surfactant
Accumulation of fluid
Atelectasis
Pulmonary edema
❶
❷
Pathophysiology Consequences of lung injury include:
Impaired gas exchange V/Q mismatch Increased dead space
Decreased compliance
PLAN The main goal is to optimize oxygenation and prevent
further inflammation that may lead to multi-organ failure and that may done by :
Low tidal volume Low PEEP/high Fio2
Initial ventilator settingsmade by ED physician were not compliantwith current therapy recommendations.
Ventilator settings were adjusted in the ICU immediately following initial evaluation.
Day 2
Ventilator management
A/C VC IBW = 90 KgVT= 8mL/Kg = 700mL PEEP= 10 cm H2ORR = 18 bpmFio2 = 100%
VT= 6mL/kg = 540mLPEEP= 14 cm H2O
Day 2
Community Acquired Pneumonia ..
For the treatment of CAP for patients in the ICU include a B-lactam, and either azithromycin or a respiratory fluroquinolone.
Patients with a penicillin allergy should receive a respiratory fluroquinolone and aztreonam.
Neuromuscular blocking agents
(NMBA) Are used : In the ICU to facilitate and optimize mechanical ventilation. To improve chest wall compliance, eliminate dysynchrony, and reduce
peak airway pressures. Muscle paralysis used :
In decreasing the work of breathing and respiratory muscle blood flow thereby reducing oxygen consumption
Cont.
The patient displayed mild ventilator dysynchrony and refractory hypoxemia.
Paralytics were initiated to gain full control of ventilation and eliminate ventilator asynchrony.
Once paralytics were initiated, the patient’s ventilator asynchrony resolved.
Day 4
Subjective data ..
• Remains critically ill.• Orally intubated on mechanical ventilation.• Oxygen saturations remain less than 86%.
Day 4
Objective data ..oVital Signs:• T = 38.4 C• Pulse = 102 B/min• RR = 20 B/min• BP = 101/52• O2 sat =84 %
Day 4
Physical examination .. No murmurs, gallops, or rubs. CV
Bilateral breath sounds with course crackles; diminished in bilateral bases; no wheezes noted. RESP
Warm, 2+ pitting edema to bilateral lower extremities, no cyanosis or clubbing noted.
EXT
Paralyzed on Nimbex drip at 3 μg/kg/min , Sedated onpropofol infusion at 50 μg/kg/min. NEURO
Day 4
• Norepinephrine at 0.5 μg/kg/min IV• Nimbex at 3 μg/kg/min IV• Propofol at 50 μg/kg/min IV• Clindamycin 600 mg IV every 8 hours• Rocephin 2 grams IV every 24 hours• Albuterol/Atrovent unit dose nebulized every 4 hours .
Day 4
Current medications ..
Chest X-ray films ..• Bilateral infiltrates and pulmonary edema • Endotracheal tube in adequate position above the
carina.
Day 4
LABORATORY DATA ..Day
4
ASSESSMENT ..• ARDS• Metabolic acidosis• Septic shock• Community acquired pneumonia• Acute renal failure• Recent influenza A (H1N1)
Day 4
PLAN ..
Despite optimal medical therapy, the patient failed conventional
treatment, and without further intervention death was eminent.
Day 4
Controversial ( adults ) Common indications for use of ECMO in adults include
postcardiotomy, postcardiac transplant, severe refractory heart failure, ARDS, pneumonia, trauma, or primary graft failure following lung transplant.
Consult cardiovascular surgeon forplacement of extracorporeal membraneoxygenation (ECMO):
Use of ECMO results in 1 extra survivor for every 6 patient treated .
A total of 201 adult patients received mechanical ventilation for confirmed or suspected influenza. 68 of these patients received ECMO and the remaining 133 received conventional mechanical ventilation.
48 patients (71%) that received ECMO survived to ICU discharge and 32 patients survived to hospital discharge. Overall mortality of the ECMO group was 21%. The researchers contributed the lower mortality to the age of the study participants and the cause of ARDS (H1N1).
Use of ECMO has a multitude of potential complications including life-threatening bleeding, coagulopathy, air embolism, thromboembolism, intracerebral hemorrhage (in neonates), and limb ischemia.
risks must carefully be weighed against benefit prior to initiation
Despite optimal medical therapy, the patient failed conventional treatment, and with- out further intervention death was eminent. After consulting cardiovascular surgery, available therapy options were discussed with the patient’s spouse and the decision was made to place the patient on ECMO as salvage therapy.
In this scenario
Continuity Of Care
VT = 4-6 ml/kg RR= 5-10 bpm PEEP= 12-15 cm H2O Inspiratory time longer FiO2= 0.21
Recommended Ventilator Settings
day 4 : taken to OR , ECMO wasinitiated.
ECMO for 6 days
day 10 ,returned to the OR for removal ofECMO and insertion of a percutaneous tracheostomy , and percutaneous endoscopic gastrostomy (PEG) tube placement
continued to make marked improvements following removal of ECMO .Day 18 :was weaned from the
ventilator. Physical therapy, occupational therapy, and speech therapy were consulted. Day 21, the patient was discharged from the ICU.
day 25 transferred to a long-term acute care (LTAC) facility for continued physical and occupational therapy
On day 25 transferred to a long-term acute care facility for continued physical and occupational therapy( 2 weeks ).
The patient was discharged to his home with no physical or cognitive deficits noted.
Since his discharge from LTAC, the patient has returned to work and has no limitations .
Summary
55 y/o male recently diagnosed with influenza A. Presented to the emergency department (ED)
accompanied by his wife with worsening shortness of breath, fever, productive cough
( green ) sputum, and new onset altered mental status.
This case study explores the management of an unusually complicated case of (ARDS) extending
over 52 days of hospitalization. Despite the utilization of conventional medical treatments
and optimum respiratory support modalities, the patient’s condition worsened and death was
imminent without salvage therapy. After cardiovascular surgery consultation, (ECMO) therapy was initiated for 6 days. The patient recovered and was able to return to regular
employment.
Conclusion Acute respiratory distress syndrome (ARDS) is a life-
threatening medical condition where the lungs can't provide enough oxygen for the rest of the body.
ARDS can affect people of any age and usually develops as a complication of a serious existing health condition.
(ARDS) has a mortality rate of 34% to 58% .